Olive O’Driscoll, CEO and Co-Founder
Olive is a biomedical engineer with 18 years’ experience in the medical device and pharmaceutical industry. She has worked in multi-national and start-up companies in business, clinical and regulatory roles in the areas of oncology, cardiovascular and orthopedics. Olive has led international clinical trials with more than 15,000 patients in 200 countries, with subsequent EU and USA clearances. Having invented and developed the Solo TTD, Olive set up AventaMed with co-founder John Vaughan in 2013.